China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the mechanism of injectable hydrogel loaded with epimedium-derived extracellular vesicles to improve knee osteoarthritis by regulating chondrocyte ferroptosis through Nrf2/HO-1/GPX4 signaling axis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130550

Registration Time: 2026/08/21

Type: Observational study

Primary Sponsor: Foshan Hospital of Traditional Chinese Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338894

Published by HT Digital Content Services with permission from Health Daily Digest....